World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
99
Citations
34549
World Ranking
754
National Ranking
67

Medicine

D-Index
100
Citations
36168
World Ranking
8288
National Ranking
811

Peter J. M. Openshaw publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter J. M. Openshaw sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 314 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Peter J. M. Openshaw D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter J. M. Openshaw sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 99 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom
  • Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Peter J. M. Openshaw is affiliated with Imperial College London in the United Kingdom. Their main field of study is Medicine, with a focus on Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine, Neurology, and Immunology. Their research topics emphasize respiratory viral infections, COVID-19 clinical research, SARS-CoV-2 and COVID-19, long-term effects of COVID-19, pneumonia and respiratory infections, tracheal and airway disorders, and COVID-19 impacts on healthcare.

Notable recent papers include:

  • Features of 20,133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study (2020, BMJ)
  • Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis (2022, The Lancet)
  • Genetic mechanisms of critical illness in COVID-19 (2020, Nature)
  • Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 (2020, Nature Immunology)
  • Risk stratification of patients admitted to hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score (2020, BMJ)

Frequent co-authors include:

  • Malcolm G. Semple
  • J. Kenneth Baillie
  • Lance Turtle
  • Annemarie B Docherty
  • Andrew J. Pollard

Common publication venues for their work are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Infectious Diseases
  • Nature Communications
  • The Lancet Respiratory Medicine
  • SSRN Electronic Journal

They have been recognized as a Fellow of The Academy of Medical Sciences, United Kingdom.

Best Publications

  • Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study.

    Annemarie B Docherty;Ewen M Harrison;Christopher A Green;Hayley E Hardwick

  • Genetic mechanisms of critical illness in Covid-19.

    E. Pairo-Castineira;E. Pairo-Castineira;S. Clohisey;L. Klaric;A. D. Bretherick

  • Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.

    Stephen R. Knight;Antonia Ho;Riinu Pius;Iain Buchan

  • Respiratory Syncytial Virus

    Akhilesh Jha;Hannah Jarvis;Clementine Fraser;Peter Jm Openshaw

  • IFITM3 restricts the morbidity and mortality associated with influenza

    Aaron R. Everitt;Simon Clare;Thomas Charles Pertel;Sinu P. John

  • Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations.

    Peter Openshaw;Erin E. Murphy;Nancy A. Hosken;Vernon Maino

  • Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study.

    Olivia V Swann;Olivia V Swann;Karl A Holden;Lance Turtle;Lance Turtle;Louisa Pollock

  • Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study.

    Rachael A Evans;Hamish McAuley;Ewen M Harrison;Aarti Shikotra

  • Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.

    Emma C. Thomson;Emma C. Thomson;Laura E. Rosen;James G. Shepherd;Roberto Spreafico

  • Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.

    M. J. Cannon;P. J. M. Openshaw;B. A. Askonas

  • Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.

    E Murphy;K Shibuya;N Hosken;P Openshaw

  • Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis.

    Ting Shi;Angeline Denouel;Anna K Tietjen;Iain Campbell

  • The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.

    Natalie I Mazur;Deborah Higgins;Marta C Nunes;José A Melero

  • Tracheostomy in the COVID-19 era: global and multidisciplinary guidance.

    Brendan A McGrath;Michael J Brenner;Stephen J Warrillow;Vinciya Pandian

  • Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection

    Peter J. M. Openshaw;John S. Tregoning

  • DISTINCT TYPES OF LUNG-DISEASE CAUSED BY FUNCTIONAL SUBSETS OF ANTIVIRAL T-CELLS

    W. H. Alwan;W. J. Kozlowska;P. J. M. Openshaw

  • Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology.

    Tracy Hussell;Alasdair Pennycook;Peter J. M. Openshaw

  • Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).

    J S Nguyen-Van-Tam;P J M Openshaw;A Hashim;E M Gadd

  • Flow cytometric measurement of intracellular cytokines.

    Pietro Pala;Tracy Hussell;Peter J.M. Openshaw

  • Age at First Viral Infection Determines the Pattern of T Cell–mediated Disease during Reinfection in Adulthood

    Fiona J. Culley;Joanne Pollott;Peter J.M. Openshaw

  • Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.

    Clark D Russell;Cameron J Fairfield;Thomas M Drake;Lance Turtle

  • Impaired Antibody-mediated Protection and Defective IgA B-Cell Memory in Experimental Infection of Adults with Respiratory Syncytial Virus.

    Maximillian S. Habibi;Agnieszka Jozwik;Spyridon Makris;Jake Dunning

  • Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.

    C. R. M. Bangham;P. J. M. Openshaw;L. A. Ball;A. M. Q. King

  • Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G.

    Peter J. M. Openshaw;Sarah L. Clarke;Fiona M. Record

  • CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection.

    Tracy Hussell;Christopher J. Baldwin;Anne O'Garra;Peter J. M. Openshaw

  • Genetic mechanisms of critical illness in Covid-19

    Erola Pairo-Castineira;Sara Clohisey;Lucija Klaric;Andrew Bretherick;Andrew Bretherick

  • Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score

    Stephen R Knight;Antonia Ho;Riinu Pius;Iain Buchan

Frequent Co-Authors

Tracy Hussell
Tracy Hussell University of Manchester
Jonathan S. Nguyen-Van-Tam
Jonathan S. Nguyen-Van-Tam University of Nottingham
Sebastian L. Johnston
Sebastian L. Johnston Imperial College London
Peter Horby
Peter Horby University of Oxford
Robert C. Read
Robert C. Read University of Southampton
Tom Solomon
Tom Solomon University of Liverpool
Karl G. Nicholson
Karl G. Nicholson University of Leicester
Maria Zambon
Maria Zambon Public Health England
Andrew J. Pollard
Andrew J. Pollard University of Oxford
Jürgen Schwarze
Jürgen Schwarze University of Edinburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various allied health careers, including nursing and specialized practitioner roles. For those considering a nursing path, finding accredited LPN programs easy to get into can be a practical starting point. These programs offer foundational clinical training with manageable admission requirements, providing a quick route into healthcare.

Advancing further, many students explore easiest online nurse practitioner programs. These flexible options allow professionals to balance work and study while gaining advanced skills necessary for independent patient care.

For those interested in mental health, pursuing a Psychiatric-Mental Health Nurse Practitioner (PMHNP) degree is a promising avenue. The best PMHNP programs provide strong clinical placements, ensuring hands-on experience in psychiatric care settings.

Affordability is often a key concern; fortunately, there are cheapest psych NP programs online that maintain quality while easing financial pressures. These programs enable students to enter the field of psychiatric nursing without incurring excessive debt.

Best Scientists Citing Peter J. M. Openshaw

Trending Scientists

Recently Published Articles